| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| VYNE Therapeutics Inc. | CHIEF SCIENTIFIC OFFICER | Common Stock | 115,239 | $66,850 | $0.5801 | 31 Dec 2025 | Direct |
| VYNE Therapeutics Inc. | CHIEF SCIENTIFIC OFFICER | Stock Option (right to buy) | 230,000 | 21 Jan 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VYNE | VYNE Therapeutics Inc. | 31 Dec 2025 | 1 | -$1,420 | 4 | CHIEF SCIENTIFIC OFFICER | 05 Jan 2026, 08:30 |
| VYNE | VYNE Therapeutics Inc. | 30 Sep 2025 | 1 | -$822 | 4 | CHIEF SCIENTIFIC OFFICER | 02 Oct 2025, 17:05 |
| VYNE | VYNE Therapeutics Inc. | 30 Jun 2025 | 1 | -$4,047 | 4 | CHIEF SCIENTIFIC OFFICER | 02 Jul 2025, 16:30 |
| VYNE | VYNE Therapeutics Inc. | 31 Mar 2025 | 1 | -$9,550 | 4 | CHIEF SCIENTIFIC OFFICER | 02 Apr 2025, 16:15 |
| VYNE | VYNE Therapeutics Inc. | 21 Jan 2025 | 1 | $0 | 4 | CHIEF SCIENTIFIC OFFICER | 23 Jan 2025, 16:15 |
| VYNE | VYNE Therapeutics Inc. | 31 Dec 2024 | 1 | -$16,271 | 4 | CHIEF SCIENTIFIC OFFICER | 02 Jan 2025, 17:45 |
| VYNE | VYNE Therapeutics Inc. | 30 Sep 2024 | 1 | -$205 | 4 | CHIEF SCIENTIFIC OFFICER | 02 Oct 2024, 16:15 |
| VYNE | VYNE Therapeutics Inc. | 01 Jul 2024 | 1 | -$265 | 4 | CHIEF SCIENTIFIC OFFICER | 03 Jul 2024, 16:15 |
| VYNE | VYNE Therapeutics Inc. | 01 Apr 2024 | 1 | -$484 | 4 | CHIEF SCIENTIFIC OFFICER | 03 Apr 2024, 17:06 |
| VYNE | VYNE Therapeutics Inc. | 01 Jan 2024 | 3 | -$358 | 4 | Chief Scientific Officer | 03 Jan 2024, 17:21 |
| VYNE | VYNE Therapeutics Inc. | 13 Dec 2023 | 2 | $0 | 4 | Chief Scientific Officer | 15 Dec 2023, 17:10 |
| VYNE | VYNE Therapeutics Inc. | 02 Oct 2023 | 1 | -$4,535 | 4 | Chief Scientific Officer | 04 Oct 2023, 16:23 |
| VYNE | VYNE Therapeutics Inc. | 30 Jun 2023 | 1 | -$619 | 4 | Chief Scientific Officer | 05 Jul 2023, 16:34 |
| VYNE | VYNE Therapeutics Inc. | 31 Mar 2023 | 1 | -$1,478 | 4 | Chief Scientific Officer | 04 Apr 2023, 17:05 |
| VYNE | VYNE Therapeutics Inc. | 31 Dec 2022 | 1 | -$258 | 4 | Chief Scientific Officer | 04 Jan 2023, 16:09 |
| VYNE | VYNE Therapeutics Inc. | 30 Sep 2022 | 1 | -$383 | 4 | Chief Scientific Officer | 04 Oct 2022, 17:05 |
| VYNE | VYNE Therapeutics Inc. | 30 Jun 2022 | 1 | -$669 | 4 | Chief Scientific Officer | 05 Jul 2022, 17:01 |
| VYNE | VYNE Therapeutics Inc. | 31 Mar 2022 | 1 | -$2,255 | 4 | Chief Scientific Officer | 04 Apr 2022, 17:09 |
| VYNE | VYNE Therapeutics Inc. | 17 Mar 2022 | 2 | $0 | 4 | Chief Scientific Officer | 18 Mar 2022, 17:10 |
| VYNE | VYNE Therapeutics Inc. | 31 Dec 2021 | 1 | -$1,275 | 4 | Chief Scientific Officer | 04 Jan 2022, 15:40 |
| VYNE | VYNE Therapeutics Inc. | 30 Sep 2021 | 1 | -$2,057 | 4 | Chief Scientific Officer | 01 Oct 2021, 17:12 |
| VYNE | VYNE Therapeutics Inc. | 02 Sep 2021 | 2 | $0 | 4 | Chief Scientific Officer | 03 Sep 2021, 17:34 |
| VYNE | VYNE Therapeutics Inc. | 30 Jun 2021 | 1 | -$10,821 | 4 | Chief Scientific Officer | 02 Jul 2021, 16:36 |